您搜索了: amantadine (英语 - 马耳他语)

amantadine
amantadina

amantadine:
amantadine:

thiazides may increase the risk of adverse effects caused by amantadine.
thiazides jistgħu jżidu r-riskju ta’ effetti avversi ikkaġunati b’amantadine.

- amantadine (which can be used to treat parkinson’ s disease)
- amantadine (li jista ’ jintuża għall- kura tal- marda ta ’ parkinson)

- amantadine (which can be used to treat parkinson’ s disease).
- amantadine (li jista ’ jintuża għal trattament tal- marda ta ’ parkinson).

thiazides, including hydrochlorothiazide, may increase the risk of adverse reactions caused by amantadine.
it-thiazides, inkluż hydrochlorthiazide, jistgħu jżidu r- riskju ta’ reazzjonijiet avversi kkawżati minn amantadina.

concomitant use of memantine and amantadine should be avoided, owing to the risk of pharmacotoxic psychosis.
l-użu ta’ memantine u amantadine għandu jkun evitat, minħabba r-riskju ta’ psikożi farmakotossika.

amantadine: thiazides, including hydrochlorothiazide, may increase the risk of adverse reactions caused by amantadine.
amantadina: it-thiazides, inkluż hydrochlorthiazide, jistgħu jżidu r-riskju ta’ reazzjonijiet avversi kkawżati minn amantadina.

administration of naltrexone / bupropion to patients receiving either levodopa or amantadine concurrently should be undertaken with caution.
l-għoti ta’ naltrexone / bupropion lil pazjenti li jirċievu jew levodopa jew amantadine fl-istess waqt għandu jsir b’kawtela.

amantadine (medicine used to treat parkinson’s disease and also used to treat or prevent certain illnesses caused by viruses).
amantadine (mediċina użata biex tikkura l-marda ta’ parkinson u tintuża wkoll bix tikkura jew tipprevjeni ċertu mard ikkawżat mill-viruses).

36 that are inhibitors of this active renal elimination pathway or are eliminated by this pathway, such as cimetidine and amantadine, may interact with pramipexole resulting in reduced clearance of either or both medicinal products.
għalhekk, prodotti mediċinali li huma inibituri ta ’ dan il- passaġġ attiv ta ’ l- eliminazzjoni renali, jew li jkunu mneħħija permezz ta ’ dan il- passagg, bħal cimetidine u amantadine, jistgħu jirreaġixxu ma ’ pramipexole, u dan jirrizulta fi tneħħija mnaqqsa ta ’ wieħed jew iż- żewġ prodotti mediċinali.

medicines shown during clinical trials not to interfere with datscan imaging include amantadine, trihexyphenidyl, budipine, levodopa, metoprolol, primidone, propranolol and selegiline.
mediċini li fil-provi kliniċi wrew li ma jxekklux il-viżjoni permezz tad-datscan jinkudu amantadine, benzhexol, budipine, levodopa, metoprolol, primidone, propranolol u selegiline.

other active substances such as cimetidine, ranitidine, procainamide, quinidine, quinine and nicotine that use the same renal cationic transport system as amantadine may also possibly interact with memantine leading to a potential risk of increased plasma levels.
sustanzi attivi oħra bħal cimetidine, ranitidine, procainamide, quinidine, quinine u nicotine li jużaw l-istess sistema ta’ trasport ketajoniku renali bħal amantadine jistgħu ukoll jinteraġixxu ma’ memantine u b’hekk jista’ jkun hemm riskju ta’ livelli ogħla fil-plażma.

concomitant use of other n-methyl-d-aspartate (nmda)-antagonists such as amantadine, ketamine or dextromethorphan should be avoided.
l-użu fl-istess ħin ta’ antagonisti-n-methyl-d-aspartate (nmda) oħra bħal amantadine, ketamine jew dextromethorphan għandu jkun evitat.

concomitant administration of memantine with the antispasmodic agents, dantrolene or baclofen, can modify their effects and a dose adjustment may be necessary. • concomitant use of memantine and amantadine should be avoided, owing to the risk of pharmacotoxic psychosis.
26 antispasmodiċi, dantolene jew baclofen, jista ’ jibdlilhom l- effetti tagħhom u jista ’ jkun hemm bżonn ta ’ bidla fid- doża. • l- użu ta ’ memantine u amantadine għandu jkun evitat, minħabba r- riskju ta ’ psikożi farmakotossika.